35 results on '"Fukihara, Jun"'
Search Results
2. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study
3. COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases
4. Idiopathic Pulmonary Fibrosis Incidentally Detected by CT Scan as Interstitial Lung Abnormalities
5. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a cohort study
6. Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease
7. Clinical burden of immune checkpoint inhibitor-induced pneumonitis
8. Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases.
9. Prediction of survival in patients with pulmonary hypertension associated with interstitial lung disease treated with pulmonary vasodilators
10. Preclinical idiopathic pulmonary fibrosis (IPF): a retrospective cohort study
11. Early intervention of antifibrotics along with anti-inflammatory treatment in rapidly progressive interstitial lung disease (RP-ILD) with anti-MDA5 antibody-positive dermatomyositis (MDA5-DM)
12. Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities.
13. Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors
14. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
15. Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
16. BMP3b Is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts
17. 骨形成蛋白経路を標的とする肺線維症の新たな治療戦略、および肺線維症に対する新規治療を受ける対象者の選択における画像パターンの重要性
18. Overexpression of bone morphogenetic protein receptor type 2 suppresses transforming growth factor ��-induced profibrotic responses in lung fibroblasts
19. COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review
20. Overexpression of bone morphogenetic protein receptor type 2 suppresses transforming growth factor β-induced profibrotic responses in lung fibroblasts
21. Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”
22. Probable usual interstitial pneumonia pattern on chest CT: is it sufficient for a diagnosis of idiopathic pulmonary fibrosis?
23. Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status
24. GDNF-mediated signaling via RET tyrosine 1062 is essential for maintenance of spermatogonial stem cells
25. Acute exacerbations of fibrotic interstitial lung diseases
26. Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease
27. Acute exacerbations of fibrotic interstitial lung diseases.
28. Lung Metastases from Bile Duct Adenocarcinoma Mimicking Chronic Airway Infection and Causing Diagnostic Difficulty
29. P3-071 - Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status
30. Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study
31. Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis
32. Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease
33. Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.
34. Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
35. Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.